Answer
It is contraindicated in people with severe hepatic impairment or hypersensitivity to selumetinib or a capsule ingredient. Suitability also requires specialist assessment of swallowing, cardiac, eye and liver risks.
Sources for this answer
- Koselugo 25 mg hard capsules — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.